Enrico Alfei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Enrico Alfei has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Gianluca Lista
Department of Neonatology and Neonatal Intensive Care Unit, V. Buzzi Children’s Hospital, 20154 Milan, Italy
2 shared publications - Irene Daniele
Division of Neonatology, Buzzi Children’s Hospital, 20154 Milan, Italy
2 shared publications - Barbara Scelsa
Department of Paediatric Neurology Buzzi Children's Hospital Milan Italy
1 shared publication - Carla Giuseppina Corti
Department of Cardio-Thoracic-Vascular Diseases – Foundation IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
1 shared publication - Caterina Colombo
Neonatologia Patologia e Terapia Intensiva Neonatale, Ospedale dei Bambini “Vittore Buzzi”, ASST Fatebenefratelli Sacco, Via Castelvetro 32, 20154 Milano, Italy
1 shared publication - Chiara Ionio
CRIdee, Unità di Ricerca sul Trauma, Dipartimento di Psicologia, Facoltà di Psicologia, Università Cattolica del Sacro Cuore, 20123 Milan, Italy
1 shared publication
Latest Publications
- Open Access
- 4 March 2022
- Published by MDPI AG in Pediatric Reports
- Vol. 14 (1) , 115-126
Cognitive, Behavioral and Socioemotional Development in a Cohort of Preterm Infants at School Age: A Cross-Sectional Study
More than 50% of children who survive prematurity have an atypical course of development at school age, as environmental demands become more demanding. This study examines the effects of preterm birth on the cognitive, behavioral and socioemotional development of 185 children at ages five and seven years. Weaknesses were found in attention, working memory, processing speed and the ability to correctly interpret emotions at both ages five and seven. Significant correlations were found in regression and moderation models. These findings suggest that school-age children who were preterm infants are at increased risk of exhibiting impairments in several developmental domains that may affect their overall quality of life.
- 4 March 2022
- Published by MDPI AG in Pediatric Reports
- Vol. 14 (1) , 115-126
Open AccessCognitive, Behavioral and Socioemotional Development in a Cohort of Preterm Infants at School Age: A Cross-Sectional Study
More than 50% of children who survive prematurity have an atypical course of development at school age, as environmental demands become more demanding. This study examines the effects of preterm birth on the cognitive, behavioral and socioemotional development of 185 children at ages five and seven years. Weaknesses were found in attention, working memory, processing speed and the ability to correctly interpret emotions at both ages five and seven. Significant correlations were found in regression and moderation models. These findings suggest that school-age children who were preterm infants are at increased risk of exhibiting impairments in several developmental domains that may affect their overall quality of life.
- Open Access
- 1 March 2021
- Published by MDPI AG in Pediatric Reports
- Vol. 13 (1) , 104-112
Efficacy of Everolimus Low-Dose Treatment for Cardiac Rhabdomyomas in Neonatal Tuberous Sclerosis: Case Report and Literature Review
Background: Cardiac rhabdomyomas (CRs) are the most common cardiac tumors in newborns. Approximately 80–90% of cases are associated with tuberous sclerosis complex (TSC). In selective cases, Everolimus has resulted in a remarkable tumoral regression effect in children with TS. The optimal dosage for neonates is still unknown. Case presentation: We describe the use of Everolimus in a neonate with multiple biventricular CRs, causing subaortic obstruction, in which a low-dose treatment (0.1 mg/die), in an effort to maintain serum trough levels of 3–7 ng/mL, was successfully used off-label, without adverse effects. Conclusions: We showed that a low-dose Everolimus regimen may be an effective and safe treatment for CR regression in TS neonates, when the minimum therapeutic range was maintained.
- 1 March 2021
- Published by MDPI AG in Pediatric Reports
- Vol. 13 (1) , 104-112
Open AccessEfficacy of Everolimus Low-Dose Treatment for Cardiac Rhabdomyomas in Neonatal Tuberous Sclerosis: Case Report and Literature Review
Background: Cardiac rhabdomyomas (CRs) are the most common cardiac tumors in newborns. Approximately 80–90% of cases are associated with tuberous sclerosis complex (TSC). In selective cases, Everolimus has resulted in a remarkable tumoral regression effect in children with TS. The optimal dosage for neonates is still unknown. Case presentation: We describe the use of Everolimus in a neonate with multiple biventricular CRs, causing subaortic obstruction, in which a low-dose treatment (0.1 mg/die), in an effort to maintain serum trough levels of 3–7 ng/mL, was successfully used off-label, without adverse effects. Conclusions: We showed that a low-dose Everolimus regimen may be an effective and safe treatment for CR regression in TS neonates, when the minimum therapeutic range was maintained.